Concarlo Holdings
Gary Schwartz is on the Board of Advisors at Concarlo Holdings. Gary is also Division Chief Hem/Onc at Columbia University Medical Center.
This person is not in the org chart
This person is not in any offices
Concarlo Holdings
Concarlo is a precision-medicine oncology company focused on diagnosing and treating cancer with an innovative approach to targeting a unique cellular pathway - p27Kip1.